Lataa...
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid
Histone deacetylase (HDAC) proteins have emerged as targets for anti-cancer therapeutics, with several inhibitors used in the clinic, including suberoylanilide hydroxamic acid (SAHA, vorinostat). Because SAHA and many other inhibitors target all or most of the 11 human HDAC proteins, the creation of...
Tallennettuna:
| Julkaisussa: | Arch Pharm (Weinheim) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927578/ https://ncbi.nlm.nih.gov/pubmed/27062198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ardp.201500472 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|